Joshua T. Anderson

Researcher

Last publication 2023 Last refreshed 2026-05-02

faculty

17 h-index 62 pubs 803 cited

Biography and Research Information

OverviewAI-generated summary

Joshua T. Anderson's research focuses on patient outcomes and treatment effectiveness, particularly within the context of workers' compensation and surgical interventions. His work has investigated factors influencing return to work following procedures such as carpal tunnel release, utilizing statewide cohort data. Anderson has also examined the role of multidisciplinary transitional pain management programs in reducing opioid dependence after total joint arthroplasty and has studied the impact of smoking on patients receiving spinal cord stimulation within workers' compensation cases.

His research portfolio includes an examination of challenges related to extensor mechanism disruptions and inconsistencies within the International Classification of Disease 10 Procedure Coding System for hip fractures. Additionally, Anderson is the Principal Investigator on a $226,693 grant from the NIH/National Institute on Drug Abuse for the validation of a survey tool to evaluate patient-reported outcomes for new medications targeting methamphetamine use disorder. His scholarship metrics include an h-index of 16, with 62 total publications and 795 total citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Benjamin M. Stronach, C. Lowry Barnes, Jeffrey B. Stambough, and Simon C. Mears.

Metrics

  • h-index: 17
  • Publications: 62
  • Citations: 803

Selected Publications

  • Inconsistency and Ambiguity Within the International Classification of Disease 10 Procedure Coding System for Hip Fractures (2023)
    4 citations DOI OpenAlex
  • Extensor Mechanism Disruption Remains a Challenging Problem (2023)
    15 citations DOI OpenAlex
  • The Role of Antiseptic Irrigation Solutions and Topical Antibiotics in Total Joint Arthroplasty. (2021)
    3 citations OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $226,693 total

NIH/National Institute on Drug Abuse Contact PI Sep 2024 - Aug 2026

Validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder: The PROMT Survey

National Institute on Drug Abuse $226,693 R21

Collaboration Network

50 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics